Nicorettequick (Nicotine)

Nicotine, the active ingredient in Nicorettequick, is a nicotine replacement therapy presented as an oromucosal formulation for buccal use. It provides controlled nicotine delivery to reduce withdrawal symptoms and cravings associated with tobacco dependence, supporting adults who wish to quit smoking.

GNH USA supplies Nicorettequick as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance and reliable delivery across global markets.

Nicotine delivered via Nicorettequick is used in nicotine replacement therapy to address tobacco dependence.

Smoking cessation: assists adult smokers in quitting by reducing nicotine cravings and withdrawal symptoms. Relapse prevention: helps maintain abstinence after initial cessation by providing controlled nicotine exposure. Nicotine dependence: alleviates withdrawal signs in individuals reducing tobacco use.

Common Side Effects: - Mouth irritation or soreness - Nausea or upset stomach - Headache - Dizziness - Throat irritation - Hiccups

Serious or Rare Side Effects: - Allergic reaction such as rash or swelling - Chest pain or palpitations - Irregular heartbeat - Severe hypotension - Anaphylaxis - Severe skin reactions like Stevens‑Johnson syndrome

Precautions: - Assess cardiovascular status: evaluate for recent heart attack before initiating therapy. - Avoid use in non‑smokers: nicotine may cause dependence in individuals not already tobacco‑dependent. - Monitor during pregnancy: discuss potential risks with a healthcare professional before use. - Do not combine with other nicotine products: concurrent use may increase nicotine exposure. - Store at room temperature: keep in the original packaging, protect from moisture and heat.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase hypertensive risk. - Beta‑blockers: nicotine may mask tachycardia, complicating monitoring. - CYP2A6 inhibitors: may alter nicotine metabolism, leading to higher systemic levels.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs): may increase nausea when combined. - Antihypertensive agents: nicotine can reduce their efficacy, requiring blood pressure monitoring.